BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16818769)

  • 1. Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ mice.
    Watson LC; Moffatt-Blue CS; McDonald RZ; Kompfner E; Ait-Azzouzene D; Nemazee D; Theofilopoulos AN; Kono DH; Feeney AJ
    J Immunol; 2006 Jul; 177(2):1120-8. PubMed ID: 16818769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that terminal deoxynucleotidyltransferase expression plays a role in Ig heavy chain gene segment utilization.
    Tuaillon N; Capra JD
    J Immunol; 2000 Jun; 164(12):6387-97. PubMed ID: 10843694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing.
    Wakui M; Kim J; Butfiloski EJ; Morel L; Sobel ES
    J Immunol; 2004 Dec; 173(12):7368-76. PubMed ID: 15585861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual germline DSP2 gene accounts for all apparent V-D-D-J rearrangements in newborn, but not adult, MRL mice.
    Kompfner E; Oliveira P; Montalbano A; Feeney AJ
    J Immunol; 2001 Dec; 167(12):6933-8. PubMed ID: 11739512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors.
    Klonowski KD; Monestier M
    J Immunol; 2000 Oct; 165(8):4487-93. PubMed ID: 11035088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage.
    Nitschke L; Kestler J; Tallone T; Pelkonen S; Pelkonen J
    J Immunol; 2001 Feb; 166(4):2540-52. PubMed ID: 11160315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partitioning of rearranged Ig genes by mutation analysis demonstrates D-D fusion and V gene replacement in the expressed human repertoire.
    Collins AM; Ikutani M; Puiu D; Buck GA; Nadkarni A; Gaeta B
    J Immunol; 2004 Jan; 172(1):340-8. PubMed ID: 14688342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected.
    Dammers PM; Visser A; Popa ER; Nieuwenhuis P; Kroese FG
    J Immunol; 2000 Dec; 165(11):6156-69. PubMed ID: 11086049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody repertoire development in fetal and neonatal piglets. II. Characterization of heavy chain complementarity-determining region 3 diversity in the developing fetus.
    Butler JE; Weber P; Sinkora M; Sun J; Ford SJ; Christenson RK
    J Immunol; 2000 Dec; 165(12):6999-7010. PubMed ID: 11120827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice.
    Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A
    Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice.
    Molano ID; Wloch MK; Alexander AA; Watanabe H; Gilkeson GS
    Clin Immunol; 2000 Jan; 94(1):24-32. PubMed ID: 10607487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of functional V(H)81X heavy chains in adult mice with an assessment of complementarity-determining region 3 diversity and capacity to form pre-B cell receptor.
    Hayden TA; Riegert P; Kline GH
    J Immunol; 2002 Aug; 169(4):1970-7. PubMed ID: 12165522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of terminal deoxynucleotidyl transferase in transgenic mice is sufficient for N region diversity to occur at any Ig locus throughout B cell differentiation.
    Bentolila LA; Wu GE; Nourrit F; Fanton d'Andon M; Rougeon F; Doyen N
    J Immunol; 1997 Jan; 158(2):715-23. PubMed ID: 8992987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.
    Robey IF; Peterson M; Horwitz MS; Kono DH; Stratmann T; Theofilopoulos AN; Sarvetnick N; Teyton L; Feeney AJ
    J Immunol; 2004 Apr; 172(7):4624-9. PubMed ID: 15034081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes.
    Itoh K; Meffre E; Albesiano E; Farber A; Dines D; Stein P; Asnis SE; Furie RA; Jain RI; Chiorazzi N
    J Exp Med; 2000 Oct; 192(8):1151-64. PubMed ID: 11034605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in the human heavy chain CDR3.
    Souto-Carneiro MM; Sims GP; Girschik H; Lee J; Lipsky PE
    J Immunol; 2005 Dec; 175(11):7425-36. PubMed ID: 16301650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal deoxynucleotidyl transferase expression during neonatal life alters D(H) reading frame usage and Ig-receptor-dependent selection of V regions.
    Marshall AJ; Doyen N; Bentolila LA; Paige CJ; Wu GE
    J Immunol; 1998 Dec; 161(12):6657-63. PubMed ID: 9862694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of terminal deoxynucleotidyltransferase-mediated N-nucleotide addition in V(D)J recombination.
    Repasky JA; Corbett E; Boboila C; Schatz DG
    J Immunol; 2004 May; 172(9):5478-88. PubMed ID: 15100289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.